Tilray Brands, Inc. (TLRY) Earnings Call Transcripts
Tilray Brands, Inc.'s Latest Earnings Call - Q3 FY2026
Tilray Brands, Inc. reported its Q3 FY2026 results with net revenue reaching $207 million, marking an 11% organic growth YoY. The company highlighted a record quarter driven by international expansion and the strategic acquisition of BrewDog, positioning Tilray as a $1.2 billion global revenue company. Gross profit increased to $55 million, up 6% from the prior year. Management reaffirmed their adjusted EBITDA guidance of $62 million to $72 million for fiscal 2026, signaling confidence in continued growth.
Reported metrics
| Metric | Value |
|---|---|
| Net Revenue | $206.7 million (beat) |
| Gross Profit | $55 million (inline) |
| Adjusted EBITDA | $10.7 million (beat) |
| Net Loss | $25.2 million (inline) |
| International Cannabis Sales | $24.1 million (beat) |
Guidance from management
Management reaffirmed their fiscal 2026 adjusted EBITDA guidance of $62 million to $72 million, indicating confidence in their strategic direction and operational execution.
What management said
Yes. I mean you answered most of it, but just specifically on the hedge for aluminum, we're currently hedging 65% to 75% of our buy on a month-to-month basis, and we're hedging a year out.
Just to supplement that a little, when Irwin talked about the acquisitions, it's more about the timing of the acquisitions because we bought those brands after the initial discussions on spring resets that already happened.
What analysts pressed on
Analysts expressed concerns about the balance between supporting international growth and stabilizing the Canadian market. Questions were also raised about the impact of rising aluminum costs on the beverage segment and the potential regulatory changes affecting hemp-derived THC products.
Main topics on the call
- International Expansion — Tilray reported a 73% YoY growth in international cannabis sales, with Germany growing 43% YoY. Management emphasized the strategic importance of consistent supply and overcoming regulatory hurdles. "Q3 was the largest q...
- BrewDog Acquisition — The acquisition of BrewDog is expected to significantly enhance Tilray's global beverage platform, adding approximately $225-$250 million in revenue. CEO Irwin Simon noted, "This transaction positions Tilray at approxima...
- Cannabis Business Performance — Tilray maintained its position as the #1 cannabis company in Canada by revenue. The Canadian cannabis business grew 8% YoY to nearly $40 million in net revenue. Management highlighted the strength of their tiered brand s...
- Beverage Segment Challenges — Beverage net revenue was $42.6 million, down from $55.9 million YoY, impacted by margin-focused actions and industry-wide softness. Project 420 delivered $33 million in annualized savings, but aluminum costs remain a hea...
Read the full Tilray Brands, Inc. transcript (Q3 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Tilray Brands, Inc.
Tilray Brands, Inc. (TLRY) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 37 calls on record spanning January 14, 2020 to July 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 37 Tilray Brands, Inc. earnings call transcripts on record, spanning January 14, 2020 to July 28, 2026. Based on this history, Tilray Brands, Inc. reports quarterly. The most recent call on file is dated July 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- TLRY
- Exchange
- NasdaqGS
- Country
- US
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 37
- First call
- January 14, 2020
- Most recent
- July 28, 2026
- Reporting cadence
- quarterly